|
Adverse Effects
Citations 111-120 of 590 total displayed.
|
Past content
(since Mar 1998):
|
- Health Agencies Update
Tainted Diet Drugs
- Bridget M. Kuehn
JAMA 2009; 301: 817-a.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
Long-term Risks of Bisphosphonates Probed
- Bridget M. Kuehn
JAMA 2009; 301: 710-711.
[Extract]
[Full text]
[PDF]
- Letters
Association of Bisphenol A With Diabetes and Other Abnormalities
- S. Stanley Young; Min Yu
JAMA 2009; 301: 720-b-721-b.
[Extract]
[Full text]
[PDF]
- Letters
Association of Bisphenol A With Diabetes and Other Abnormalities
- Sarah Howard; Timothy G. Howard
JAMA 2009; 301: 720-a.
[Extract]
[Full text]
[PDF]
- Letters
Association of Bisphenol A With Diabetes and Other Abnormalities
- Ming Wei
JAMA 2009; 301: 720.
[Extract]
[Full text]
[PDF]
- Letters
Association of Bisphenol A With Diabetes and Other Abnormalities—Reply
- David Melzer; Iain A. Lang; Tamara S. Galloway
JAMA 2009; 301: 721-722.
[Extract]
[Full text]
[PDF]
- Original Contributions
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF- Agents
- Anja Strangfeld; Joachim Listing; Peter Herzer; Anke Liebhaber; Karin Rockwitz; Constanze Richter; Angela Zink
JAMA 2009; 301: 737-744.
[Abstract]
[Full text]
[PDF]
- Editorials
Herpes Zoster in the Age of Focused Immunosuppressive Therapy
- Richard J. Whitley; John W. Gnann Jr
JAMA 2009; 301: 774-775.
[Extract]
[Full text]
[PDF]
- Book and Media Reviews
The Voice: A Memoir
- Tony Miksanek
JAMA 2009; 301: 677.
[Extract]
[Full text]
[PDF]
- Caring for the Critically Ill Patient
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients: A Randomized Trial
- Richard R. Riker; Yahya Shehabi; Paula M. Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D. Margolis; Daniel W. Byrne; E. Wesley Ely; Marcelo G. Rocha; for the SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group
JAMA 2009; 301: 489-499.
[Abstract]
[Full text]
[PDF]
|
|
